kinetabio.com - KA Revenue Growth Rate YoY (Last Twelve Months)

Brandmark of Kineta, Inc. (KA)

The development of immune activation agents is constrained by patents and the immense financial risks associated with early-stage testing. The 12-month revenue trajectory illustrates current dynamics, where the actual level equals 0.00. Kineta, Inc. (KA) seeks to confirm the efficacy of its anti-tumor drugs, yet the suspension of research to cut costs and uncertainty regarding management's actions cast doubt on the assets' ability to recover from the crisis.

Kineta Inc - KA Sales Growth YoY (TTM) (period 02/11/2024 - 02/20/2024)

Summary analytical data breakdowns for Kineta (KA)

- market value and analyst target forecast:
Summary company analytics:KA (Kineta Corp)
Manufactured product of kinetabio.com

To assess the asset quality of Kineta, Inc. (KA), it is critical to track revenue scaling rates amid the outsourcing of antibody production. By analyzing year-over-year sales dynamics over the last four quarters, an investor can observe the daily price action of turnover over twelve months, enabling the timely identification of capital freeze risks in inventories should the company's liquidity levels prove insufficient.

Competitors of Kineta, Inc. (KA)

Sales Growth YoY (TTM) NantKwest IBRX|IMCR - Sales Growth YoY (Last Twelve Months)|JANX (januxrx.com) - Sales Growth YoY (Last 12 Months)|Arcus Corp (RCUS) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Zymeworks Corp (ZYME)|Revenue Growth YoY (Last 12 Months) TNGX|IOVA - Revenue Growth Rate YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) IMTX (Immatics Corp)|Revenue Change YoY (Last 12 Months) XNCR|Sales Growth YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Revenue Dynamics YoY (Last Twelve Months) REPL|lyell.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Innate Pharma S.A|Pyxis (PYXS) - Sales Growth YoY (Last Twelve Months)|Compugen Ltd - Revenue Dynamics YoY (Last Twelve Months)|IOBT (iobiotech.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) Sutro Biopharma Inc.|Sales Growth YoY (Last Twelve Months) MiNK Therapeutics (INKT)|HOWL: Trailing Twelve Months Sales Growth|Immix Biopharma - Revenue Growth YoY (Last 12 Months)|ALX Oncology (ALXO) - Trailing Twelve Months Revenue Growth|CUE: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth PDSB|sonnetbio.com (SONN) - Sales Growth YoY (Last Twelve Months)|MAIA Biotechnology Inc (MAIA) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) liminatuspharma.com|Sales Growth YoY (Last Twelve Months) LVTX|Revenue Growth YoY (Last 12 Months) NXTC (NextCure, Inc.)|LPTX: Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) intensitytherapeutics.com INTS|Sensei Bio (SNSE) - Trailing Twelve Months Revenue Growth|TOVX: Revenue Growth YoY (Last 12 Months)|Gritstone bio - Revenue Change YoY (Last 12 Months)|NEXI (neximmune.com) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Turnstone Biologics Corporation (TSBX)|Revenue Growth YoY (Last 12 Months) VCNX|HARP: Revenue Dynamics YoY (Last Twelve Months)